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Introduction
Brachial plexus avulsion is a devastating injury most com-
monly affecting young adults following motorcycle acci-
dents. Excessive lateral flexion of the neck towards the 
contralateral side or traction of the arm can lead to inter-
ruption of the roots at the surface of the spinal cord; this is 
effectively a central nervous system injury and often 
described as “longitudinal spinal cord injury.”
1 Involvement 
of all 5 sets of the dorsal and ventral roots (C5 to T1) leads 
to a completely paralyzed and anesthetic arm, with associ-
ated neuropathic pain. Pioneering reimplantation surgery 
has been trialed in patients with such injury.
2 This proce-
dure involves the implantation of the avulsed ventral roots 
back in the spinal cord through a slit of the pia mater and   
a small superficial incision in the ventrolateral spinal cord. 
Studies have shown significant reduction in the number of 
motor neurons lost and return of some function mainly in 
the proximal muscles of the upper limb.
1,3 In the majority 
of these patients, the spinal cord appears normal, but   
motoneuron cell death and Wallerian degeneration have 
been described in experimental models of brachial plexus 
avulsion.
4
Advanced magnetic resonance imaging (MRI) techniques 
have the potential to provide information on the structural 
and functional changes occurring in the spinal cord after 
injury, both at the level of the lesion and at distances from   
the site of injury. One of these techniques, proton magnetic 
resonance spectroscopy (
1H-MRS), albeit technically chal-
lenging, has been applied to the spinal cord of patients with 
neurological diseases. Optimized protocol for quantitative 
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Abstract
Objective. To investigate metabolic changes within the spinal cord using proton magnetic resonance spectroscopy (
1H-MRS) 
and determine their relationship with clinical function in patients with complete brachial plexus avulsion who underwent 
reimplantation of the ventral roots. Methods. Single-voxel 
1H-MRS of the cord between C1 and C3 was performed in 10 
patients with normal spinal cord on MRI, who underwent reimplantation of C5 to T1 ventral roots on average 5.5 years 
earlier, and 19 healthy controls. The ratios of the concentrations of the following main metabolites, with respect to total 
creatine levels, were obtained: total N-acetyl-aspartate, choline-containing compounds, creatine and phosphocreatine (Cr), 
and myo-inositol (m-Ins). Patient disability was assessed using upper limb scales. Differences in metabolite concentration 
ratios and their correlations with disability were investigated. Results. Patients showed increased m-Ins/Cr ratio compared 
with controls, which was associated with the level of function of the affected arm and time from injury. Conclusions. The 
finding of increased m-Ins/Cr in patients suggests that reactive gliosis, perhaps in response to the degeneration of avulsed 
fibers, may occur in the spinal cord above the site of injury and be relevant to motor dysfunction. However, this pathological 
process appears to diminish with time. These insights underline the need to integrate metabolic imaging with structural and 
functional magnetic resonance imaging to obtain a complete view of spinal cord plasticity. Last, this study provides the first 
steps toward identifying markers to serve as outcome measures for trials comparing strategies of plexus repair following 
avulsion injury.
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(single voxel) 
1H-MRS has been shown to provide reliable 
spectra especially for voxels placed in the upper cervical 
cord.
5 In patients with cord tumors, multiple sclerosis, 
chronic cervical spondylotic myelopathy, and chronic 
whiplash,
6-9 
1H-MRS has demonstrated abnormal concen-
trations of metabolites that reflect specific pathological 
processes. The most commonly reported finding is a 
reduced concentration of N-acetyl-aspartate, which is con-
sidered to reflect axonal loss and/or dysfunction.
10
The present study applies 
1H-MRS of the upper com-
plete cervical cord (ie, above the site of injury) to patients 
with complete brachial plexus root avulsion who have 
received re-implantation, to investigate whether metabolic 
abnormalities are present in this region and whether there is 
a relationship between metabolite levels and neurological 
disability.
Methods
Subjects
Ten chronic subjects (mean age, 35 years; SD, 10.8; all 
men) treated with re-implantation of avulsed spinal cord 
roots in our unit and 19 age-matched and sex-matched 
healthy subjects (mean age, 36.1 years; SD, 10.7; 18 men) 
were studied. Patients were recruited from our database of 
brachial plexus re-implantations. Only patients with com-
plete brachial plexus injury confirmed with open explora-
tion of the brachial plexus were included in the study. 
Traumatic meningocoeles were observed in 2 patients. 
Computed tomography myelogram demonstrated appear-
ances suggestive of complete brachial plexus avulsion in 5 
patients. Patients with abnormal signal within the spinal 
cord on conventional MRI, spinal canal stenosis, clinical 
signs unrelated to the brachial plexus injury (eg, leg weak-
ness), and MRI incompatible metal implants were excluded 
from the study.
All patients underwent ventral root re-implantation within 
1 month from the day of their injury. The mean duration from 
injury to assessment for this study was 5.5 years (SD, 4.3).
The study was approved by the regional ethics commit-
tee, and informed (and written) consent was obtained from 
all patients and healthy volunteers participating in the study.
Clinical Assessment
On the day of the scan, patient disability was assessed using 
the following scales: (a) Disability for Arm, Shoulder and 
Hand (DASH), which is a 30-item self-report questionnaire 
designed to measure physical function and symptoms in 
people with musculoskeletal disorders of the upper limb. A 
higher score indicates greater disability;
11 (b) Visual 
Analogue Pain Scale (VAS), a widely used tool for measur-
ing pain by asking the patient to indicate his/her perceived 
pain intensity by marking a point along a 100-mm horizontal 
line;
12 (c) Michigan Hand Outcomes Questionnaire (MHQ), 
which is a hand-specific questionnaire including 6 sub-
scales: overall hand function, activities of daily living 
(ADL), pain, work performance, and patient satisfaction 
with hand function and aesthetics. Higher scores indicate 
better hand function, except for the pain subscale on which 
higher scores correspond to more pain;
13 (d) Medical 
Research Council (MRC) muscle strength scale for the 
upper limb, which included 7 muscles scored from 0 to 5.
Magnetic Resonance Protocol and Spectroscopy
All magnetic resonance data were collected on a Magnetom 
Tim Trio 3T system (Siemens AG, Erlangen, Germany), 
using the posterior half of a 12-channel head coil, the pos-
terior part of a neck array coil, and the upper element of the 
spine array coil.
All subjects underwent conventional T2 sagittal and coro-
nal images (sagittal-oblique: turbo spin echo with effective 
TE = 96 ms; TR = 3 s; parallel imaging with acceleration 
factor 2; field of view [FoV] 220 mm
2, in-plane resolution 
0.69 × 0.92 mm
2, slice thickness 1.5 mm, gap 0.15 mm;   
coronal-oblique: 3D-HASTE with TE = 247 ms; TR = 3 s; 
parallel imaging with acceleration factor 2, FoV 200 mm
2, 
in-plane resolution 0.78 × 0.78 mm
2, 52 partitions, slice 
thickness 0.8 mm), which confirmed the normal radiological 
appearance of the spinal cord in all patients. These scans 
were acquired aligned with the main axis of the spinal cord, 
essential for correctly positioning the spectroscopy voxel.
Single-voxel spectra were obtained by cardiac-gated 
point resolved spectroscopy (PRESS) sequence with TR ≅ 
3000 ms (depending on the cardiac cycle), TE = 30 ms, and 
160 averages, with chemical-shift-selective (CHESS) water 
suppression.
14 We used the PRESS sequence provided by 
the manufacturer, and no additional saturation bands were 
used. The excitation frequency was −2.3 ppm, with respect 
to the water reference frequency, that is, 2.4 ppm. Readout 
bandwidth was 1200 Hz (1024 points collected). Our longer 
TR compared with previous studies reduced sensitivity to 
metabolites T1 changes. A non–water-suppressed spectrum 
(2 averages) was also acquired for eddy-current correction. 
As suggested by Cooke et al,
5 the spectroscopic voxel 
(mean volume of all subjects including patients and healthy 
volunteers of 2.4 mL, SD 0.6 mL) was placed along the 
main axis of the cord, centered at C2 spinal level with its 
prescription boundaries completely contained within the 
cord on the T2-weighted images in all 3 planes (Figure 1). 
To increase the spectroscopy signal, we increased the length 
of spectroscopy voxel to maximum possible length so that 
the voxel spanned between C2 and C3 spinal levels. Optimal 
shim currents for all first-order (X, Y, and Z) and second-
order (Z
2, ZX, ZY, X
2-Y
2, and XY) shim gradients were cal-
culated off-line with in-house software based on   
(a) acquisition of field maps (gradient-recalled sequence 
generating 2 images with TE = 4.92 ms and TE = 7.38 ms, 
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respectively, 2 mm isotropic resolution, 1 minute acquisi-
tion time) and (b) minimization of the magnetic field varia-
tion within the prescribed MRS voxel using calibrated field 
maps for each shim coil.
15,16 Data from 2 healthy controls 
and 1 patient were not used because of incorrect/failed 
shimming procedures.
All MRS spectra were analyzed by means of the user-
independent fitting LCModel 6.1
17 within the 0.2 to 4.0 
ppm range. Examples of patient spectra are shown in Figure 
2. Ratios of the following metabolite concentrations were 
calculated with respect to total creatine (Cr) concentration 
(creatine plus phosphocreatine): N-acetyl-aspartate (NAA = 
NAA plus NAAG), total choline (Cho = GPC plus phospho-
choline), and myo-inositol (m-Ins). LCModel standard 
error estimates (%SD, Cramer-Rao lower bounds) were 
used to assess the confidence of the concentration estimates. 
Spectra for 3 controls and 1 patient with %SD of (Cr) >21% 
were excluded. Thus, the final MRS data came from 14 
healthy controls (13 men and 1 woman; mean age, 36.1 
years [SD, 10.7]) and 8 patients (all men; mean age, 35 
years [SD, 10.8]). The FWHM and SNR values (mean ± 
SD) estimated by LCModel were 14 ± 2 Hz and 2.4 ± 0.8, 
respectively, for the healthy subjects and 12 ± 4 Hz and 2.8 
± 1.0, respectively, for the patient group (2.4 ± 0.8 for all 
patients). There was no statistical difference in FWHM 
between the 2 groups, t(21) = 0.12, P = .91. M-Ins/Cr ratio 
was excluded from the analysis in 3 controls because of 
%SD of m-Ins >21%. NAA/Cr was excluded in 3 different 
controls and 1 patient because of %SD for tNAA >21%. 
The procedure of excluding single values of metabolite 
concentrations when associated with high %SD values has 
been performed in previous MRS studies.
7 Moreover, the 
analysis was repeated without the spectra for subjects with 
%SD values greater than 21, and results did not change sig-
nificantly (results not shown). The group mean %SD values 
obtained by LCModel analysis for the main metabolites in 
the patient group were 12, 15, 12, and 12 for Cr, NAA, 
m-Ins, and Cho, respectively. The corresponding values for 
healthy volunteers were 11 for Cr, 13 for NAA, 16 for 
m-Ins, and 14 for Cho. Finally, the overall chemical shift 
was fairly small in terms of volume shift and mispositioning 
of the VOI.
Statistical Analysis
STATA statistical software version 10.1 (StataCorp LP, 
College Station, Texas) was used for statistical analysis. 
Data for each metabolite were tested for normal distribution 
and for homogeneity of variances. Differences in metabo-
lite ratios between groups were estimated using the 2-sample 
t test. The relationship between disability and metabolite 
ratios was tested in patients using multiple linear regres-
sion, using the clinical scores, in turn, as the dependent 
variable and the metabolite ratios as independent variables, 
Figure 1. (A) Location of the spectroscopic voxel between C1 and C3 on the T2-weighted sagittal image of one control. (B) Spectrum 
derived from voxel in (A) that shows reduced myo-inositol (m-Ins)/creatine and phosphocreatine (Cr) ratio (1.37 [%SD = 11]) in 
comparison with a spectrum obtained in a patient (m-Ins/Cr = 2.11 [%SD = 10]) (C).
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correcting for age. Statistical significance was accepted   
at the 5% level (P < .05).
Results
Patients showed an increase in m-Ins/Cr values when com-
pared with healthy controls, t(21) = −3.73; 95% confidence 
interval [CI] = −1.05 to −0.29; P = .001 (Table 1 and Figure 
1). NAA/Cr and Cho/Cr ratios did not differ between 
groups (Table 1).
The multiple linear regression showed that m-Ins/Cr 
ratio was independently associated with both upper limb 
disability and time from injury (R
2 = 84%; F = 13.56; P = 
.01). In particular, a higher m-Ins/Cr ratio correlated with 
greater disability, as measured by the DASH scale, t(7) = 
2.86; 95% CI = −0.001 to −0.02; P = .035 (Figure 3), and 
with shorter time from injury, t(7) = −5.15; 95% CI = −0.02 
to −0.006; P = .004 (Figure 4). No statistical correlation 
was found between MHQ, VAS, and MRC muscle strength 
scale for the affected upper limb and metabolite concentra-
tions. The time difference from injury to scan did not alter 
the regression models of NAA/Cr and Cho/Cr.
Discussion
Our findings suggest that quantification of metabolites 
through 
1H-MRS of the upper cervical cord above the site 
of injury provides insights into the underlying pathological 
processes, suggesting that 
1H-MRS may prove to be a use-
ful tool in predicting outcome in this group of patients. In 
this study, patients showed a significantly greater m-Ins/Cr 
ratio when compared with controls. This is a novel finding, 
Table 1. Mean and Standard Deviation of the Ratios of the Main 
Metabolites With Respect to Creatine (plus Phosphocreatine) 
Obtained in Patients With Brachial Plexus Reimplantation and 
Healthy Controls
Ratio
Controls,  
Mean (SD)
Patients,  
Mean (SD) P Value
NAA/Cr 1.19 (0.29) 1.21 (0.38) .85
m-Ins/Cr 1.18 (0.38)  1.86 (0.41)
a .01
Cho/Cr 0.30 (0.08) 0.33 (0.45) .45
Abbreviations: NAA, N-acetyl-aspartate; m-Ins, myo-inositol; Cho, 
choline-containing compounds.
aStatistical difference between patients and controls.
Figure 2. Examples of 3 spectra (gender, years of age): (A) male, 21; (B) male, 47; (C) male, 43.
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which has not been observed in previous 
1H-MRS studies 
of patients with spinal cord lesions.
6,8 Only a marginally 
increased m-Ins has been detected in the spinal cord of 
patients with multiple sclerosis with acute
7 and chronic 
lesions
18 when compared with controls. Increased m-Ins 
suggests that reactive gliosis, including proliferation and 
astrocytic hypertrophy, may occur in the spinal cord above 
the site of injury, possibly in response to the Wallerian 
degeneration of avulsed neuronal fibers. This is in agree-
ment with (a) increase in vimentin (VIM) glial fibrillary 
acidic protein (GFAP) immunoreactivity, which is a marker 
of proliferation of astrocytes and gliosis, described in ani-
mal models of acute and chronic stage after spinal cord 
injury
19,20 and (b) proliferation of astrocytes forming a 
nonpermissive glial scar surrounding the transitional zone, 
found in models of nerve root avulsion injury.
4,21,22 In this 
later experimental model, up to 50% motoneurons are lost 
in the relevant spinal cord segment and further neuronal 
loss occurs over time.
4,21,22
In patients, a higher m-Ins/Cr ratio was associated with 
greater disability of the arm, indicated by a higher DASH 
score, suggesting that metabolic damage in the spinal cord of 
chronic patients treated with brachial plexus re-implantation 
may be relevant to clinical function of the corresponding 
arm. It is interesting to note that the DASH scale is a 
patient-reported outcome measure (PROM), which mea-
sures severity of symptoms by taking into account the 
patient’s perspective.
23 Therefore, it may be useful in the 
future to integrate this PROM into assessment of patients 
with brachial plexus avulsion and spinal cord injury, since 
it may complement more direct measures of upper limb 
strength. We also found that a greater m-Ins/Cr ratio   
correlated with shorter time from injury, suggesting that 
gliotic changes may normalize over time, possibly reflect-
ing reorganization in the spinal cord. To confirm the 
hypotheses above, we are planning studies that will obtain 
pre-repair MRS along with further prospective MRS exam-
inations during the rehabilitation period.
Reduced NAA levels indicate both axonal loss and met-
abolic dysfunction.
9,10 The aim of re-implantation surgery 
is to achieve regeneration of new axon fibers from the 
avulsed root into the spinal cord. Hence, if the surgery 
were successful, one would expect an increase in NAA/Cr 
ratio with time. In this group of patients, there was no sta-
tistical relationship between NAA/Cr ratio and time from 
injury. The NAA/Cr ratio was similar in patients and con-
trols, suggesting a recovery of axonal numbers either by 
direct axonal regeneration or sprouting. In previous studies 
of patients with chronic whiplash and cervical spondylotic 
myelopathy,
6,8 and in patients with multiple sclerosis,
18,24 a 
lower NAA/Cr ratio was seen when compared with con-
trols. In addition, patients studied 0.5 to 2 years after spinal 
cord injury showed higher NAA levels in the ipsilateral 
occipital cortex and motor cortex when compared with 
controls.
25 In patients with multiple sclerosis, the acute 
reduction in NAA at the onset of an acute relapse was fol-
lowed by a sustained, albeit partial, increase over time.
7 
The lack of difference in NAA/Cr ratio in our study may be 
due to the small number of patients and low statistical 
power, or a true increase in nerve fibers, which perhaps 
have not made functional synapses. Therefore, future stud-
ies will investigate whether NAA is reduced in the spinal 
cord after brachial plexus injury in the acute phase and then 
normalizes over time. A key question is whether patients 
who did not undergo re-implantation show significantly 
reduced levels of NAA and increased m-Ins compared with 
patients who underwent re-implantation. Unfortunately, 
untreated patients are extremely rare. Future and collabora-
tive work, perhaps with a multicenter setting, may be able 
Figure 3. Scatter plots showing the relationship between m-Ins 
and DASH score. Abbreviations: m-Ins, myo-inositol; Cr, total creatine; 
DASH, Disability for Arm, Shoulder and Hand score.
Figure 4. Scatter plot showing the relationship between m-Ins 
and months from injury. Abbreviations: m-Ins, myo-inositol; Cr, total 
creatine.
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to address this question, which is relevant for forthcoming 
clinical trials with stem cell transplantation.
26
Our findings suggest that metabolic changes occur in 
patients after brachial plexus root re-implantation at sites 
that are distant to the site of primary damage and that these 
changes may be clinically relevant. The small number of 
reimplanted patients recruited in this study, which was due 
to both the unique group of patients and local constraints in 
scanning patients with metal implants, is a limitation of our 
study. In addition, spectroscopic analysis has been limited 
to NAA, choline, and myo-inositol, whereas other poten-
tially measurable metabolites such as lactate (Lac) and glu-
tamine/glutamate (Gln/Glu) have not been studied. Lac   
resonance is at the very limit of detectability in most brain 
MRS studies because of the low concentration of Lac under 
normal conditions but is often detectable in pathological 
conditions where anaerobic metabolism ensues. However, 
our patients are well into the chronic stage of their injury 
and such elevations would not persist years after the injury. 
Second, Lac resonance is difficult to distinguish because of 
overlapping lipid resonances and requires long echo time 
(˜140 ms) or other spectral editing techniques. To our 
knowledge, Lac spectra from the spinal cord have been 
acquired in one study of cervical spondylotic myelopathy 
patients in the acute stage, where Lac peaks were demon-
strated in 7 out of 21 patients, 6 of which had T2 signal 
abnormality in the same region of the spinal cord.
8 
Furthermore, Gln/Glu quantification is complex and chal-
lenging and to our knowledge has not been reported in the 
spinal cord to date. We aim to perform pretreatment MRS 
and prospective longitudinal follow-up MRS studies during 
the rehabilitation period to demonstrate temporal changes in 
the spinal cord and correlate to clinical recovery, which will 
also enable us to obtain Lac spectra during the acute stage.
Despite the above limitations, the study opens promising 
perspectives for further applications of spinal cord MRS to 
patients with spinal cord injuries. Future studies are needed 
to combine functional MRI with metabolic and structural 
MRI and correlate pretreatment MRS to longitudinal follow-
up MRS to better understand recovery after spinal cord injury 
and fully characterize central nervous system plasticity,
27 
which is the ultimate goal of multimodal imaging. Last, the 
current study provides the first steps toward identifying 
markers to serve as outcome measures for trials comparing 
strategies of brachial plexus repair following avulsion injury.
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